Suchergebnisse
Alle Typen
Vortrag (253)
361.
Vortrag
A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. 3rd Japan-Switzerland-Germany Workshop on Biocatalysis and Bioprocess Development
, Aichi (Japan) (2023)
362.
Vortrag
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 17th Vaccine Congress, Glasgow (Scotland) (2023)
363.
Vortrag
Reverse genetics for Influenza a virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. Vir-AI-DIP Workshop , Hamburg (Germany) (2023)
364.
Vortrag
Intensified cell-based virus production: A process development challenge for multiple cell-virus combinations. 16th PEACe Conference, Sitges (Spain) (2023)
365.
Vortrag
Next-Generation Virus Production: From Clone, to AMBR, to Perfusion and Very High Virus Yield. International Society for Vaccines (ISV) Annual Congress, Lausanne (Switzerland) (2023)
366.
Vortrag
Increase in supply through use of new technologies for high yield vaccines. Flanders Vaccine, Brussels (Belgium) (2023)
367.
Vortrag
Intensified production for a yellow fever - ZIKA virus vaccine candicate. Democratization of biotherapies: new manufacturing modalities and intensification's, Oxford, UK (2023)
368.
Vortrag
Intensifiying OSB processes for high titer virus production. 5th large scale meeting: Orbital shaken bioreactors, Girona (Spain) (2023)
369.
Vortrag
Identification of newly synthesized proteins in microbial communities using BONCAT and click chemistry. 5th International Metaproteomics Symposium, Avignon (France) (2023)
370.
Vortrag
Process development for multi-gram-scale synthesis of nucleotide sugars using in-vitro multi-enzyme cascades. Eurocarb21 (The 21st European Carbohydrate Symposium), Paris (France) (2023)
371.
Vortrag
Development of an in-vitro multi-enzyme cascade for the synthesis of uridine diphosphate N-acetylgalactosamine using a DoE approach. GlycoBioTec 2023, Berlin, Germany (2023)
372.
Vortrag
Absolute quantification of influenza A virus proteins during single-round replication in different host cells. 6th Workshop on Virus Dynamics, Nagoya (Japan) (2023)
373.
Vortrag
Influenza A virus defective interfering particles as antiviral agents. 32nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)
374.
Vortrag
Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivo. Cell Culture Engineering (CCE) XVIII , Cancun (Mexico) (2023)
375.
Vortrag
In-depth characterization and cell culture-based production of influenza A virus defective interfering particles. ACTIP fellowship session, Dublin (Ireland) (2023)
376.
Vortrag
Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy. Vir-AI-DIP Workshop, Hamburg (Germany) (2023)
377.
Vortrag
Activated sugar for oligosaccharides synthesis. GlycoBioTec 2023, Berlin, Germany (2023)
378.
Vortrag
OP7, a defective interfering particle with mutations: in vitro infection experiments, intracellular model, impact of mutations and mode of antiviral action. 6th Workshop on Virus Dynamics, Nagoya (japan) (2023)
379.
Vortrag
Multiscale model of influenza A virus and defective interfering particle co-infection in animal cell culture. Vir-AI-DIP Workshop, Hamburg (Germany) (2023)
380.
Vortrag
Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme Cascade. GlycoBioTec 2023, Berlin, Germany (2023)